SANTA BARBARA, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) — Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics firm targeted on enhancing lives by advancing the artwork of cosmetic surgery, at present introduced that it intends to supply and promote in an underwritten public providing, topic to market and different circumstances, shares of widespread inventory (or widespread inventory equivalents). Each share of widespread inventory (or widespread inventory equal) shall be offered with a warrant to buy one share of the Company’s widespread inventory. The Company expects to grant the underwriter a 30-day choice to buy extra shares of widespread inventory and/or extra widespread inventory buy warrants on the public providing value, much less underwriting reductions and commissions. All of the securities within the providing are to be provided by the Company. The providing is topic to market and different circumstances, and there may be no assurance as as to if or when the providing could also be accomplished, or as to the precise measurement or phrases of the providing. Sientra intends to make use of any internet proceeds obtained from this providing for common working capital functions.
Craig-Hallum Capital Group is performing as sole managing underwriter for the proposed providing.
A shelf registration assertion on Form S-3 (File No. 333-264888) referring to the securities being provided was filed with the Securities and Exchange Commission (the “SEC”) and have become efficient on May 27, 2022. The providing is being made solely by way of a prospectus complement and accompanying prospectus that type part of the shelf registration assertion. A preliminary prospectus complement and the accompanying prospectus referring to and describing the phrases of the providing shall be filed with the SEC, and shall be obtainable on the SEC’s web site at http://www.sec.gov. Electronic copies of the preliminary prospectus complement and accompanying prospectus could also be obtained by contacting Craig-Hallum Capital Group LLC, 222 South Ninth Street, Suite 350, Minneapolis, MN 55402, Attn: Equity Capital Markets, by phone at (612) 334-6300 or by e-mail at [email protected]. Before investing within the providing, you must learn of their entirety the preliminary prospectus complement and accompanying prospectus and the opposite paperwork that Sientra has filed with the SEC which might be integrated by reference in such preliminary prospectus complement and the accompanying prospectus, for extra full details about Sientra and the proposed providing.
This press launch shall not represent a proposal to promote or the solicitation of a proposal to purchase these securities, nor shall there be any sale of those securities in any state or different jurisdiction during which such provide, solicitation or sale could be illegal previous to the registration or qualification beneath the securities legal guidelines of any such state or different jurisdiction.
About Sientra
Headquartered in Santa Barbara, California, Sientra is a medical aesthetics firm solely targeted on cosmetic surgery. The Company’s mission is to supply proprietary improvements and unparalleled partnerships that radically advance how plastic surgeons assume, work and care for his or her sufferers. Sientra has developed a broad portfolio of merchandise with technologically differentiated traits, supported by impartial laboratory testing and robust medical trial outcomes. The Company’s product portfolio contains its Sientra spherical and formed breast implants, the primary fifth era breast implants accredited by the FDA on the market within the United States, its ground-breaking Allox2® breast tissue expander with patented dual-port and integral drain expertise, the AuraGen fats grafting system, and BIOCORNEUM®, the #1 performing, most well-liked and advisable scar gel of plastic surgeons(*).
(* ) Data on file
Investor Relations Contact
Aman R. Patel, CFA
